- Home
- CIM vs BLFS Comparison
CIM vs BLFS Comparison
Compare CIM & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIM | BLFS |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2007 | 1989 |
Fundamental Metrics
Financial Performance| Metric | CIM | BLFS |
|---|---|---|
| Price | $12.48 | $26.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $15.25 | ★ $31.50 |
| AVG Volume (30 Days) | ★ 823.7K | 331.9K |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | ★ 11.67% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $191,573,000.00 | $100,144,000.00 |
| Revenue This Year | $11.44 | $20.67 |
| Revenue Next Year | $21.50 | $14.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 87.53 |
| 52 Week Low | $9.85 | $19.10 |
| 52 Week High | $15.37 | $29.62 |
Technical Indicators
Market Signals| Indicator | CIM | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 60.34 |
| Support Level | $12.30 | $23.58 |
| Resistance Level | $12.81 | $25.63 |
| Average True Range (ATR) | 0.25 | 0.82 |
| MACD | -0.04 | 0.12 |
| Stochastic Oscillator | 26.03 | 95.23 |
Price Performance
Historical ComparisonAbout CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.